Single-use Bioprocessing Market Size (2024 - 2029)

Single-use Bioprocessing Market Analysis

The Single-use Bioprocessing Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 2.9 billion by 2029, at a CAGR of 16.26% during the forecast period (2024-2029).

Factors such as faster implementation of single-use bioprocessers and lower risk of product cross-contamination, increasing demand for biopharmaceuticals, lower costs, and lesser environmental impact of single-use bioprocessing technologies are expected to boost market growth.

The demand for biopharmaceuticals is increasing due to the high population suffering from chronic diseases. This raises the need for effective drugs and products for their treatment. For instance, according to the data updated by the Spanish Network of Cancer Registries (REDECAN) in January 2023, about 279,260 new cases of cancer were diagnosed in Spain at the end of 2023, out of which 42,721 were colorectal cancer, 31,282 were lung cancer, and 21,694 were urinary bladder cancer. Thus, with the growing burden of cancer among the population, the demand for novel drugs and therapies is expected to increase, which, in turn, is anticipated to boost demand for single-use technologies and related products for drug development, thereby propelling market growth.

Additionally, the increasing adoption of single-use technologies and products across biopharmaceutical companies to reduce the risk of cross-contamination is further expected to fuel market growth over the forecast period. For instance, in April 2023, Cytiva, an American-based company, launched X-platform bioreactors to streamline the single-use upstream bioprocessing operations. The newly launched bioreactors boost process efficiency via production capability, ergonomic improvements, and streamlined supply chain operations. This rapid implementation allows manufacturers to respond swiftly to changing market demands and production schedules, which is expected to increase operational efficiency and upsurge the growth of the single-use bioprocessing market over the forecast period.

Furthermore, the advantages offered by single-use systems propel their adoption across the biopharmaceutical industry, boosting market growth. For instance, according to an article published by American Pharmaceutical Review in April 2023, single-use systems enhanced speed and efficiency, allowing for rapid bioprocessing setup and progressive manufacturing of multiple products at various scales within the same facility. In addition, the flexibility of SUS enabled more adaptability, allowing for seamless transitions from R&D to full-scale production or the manufacturing of different products. Thus, such benefits offered by single-use systems showed improvement throughput and scalability, thus enabling developers and manufacturers to bring products to market more quickly.

Moreover, the rising new product launches by key players further fuel the availability of single-use bioprocessing products in the market, which is expected to propel market growth. For instance, in April 2023, Merck launched the Ultimus Single-Use Process Container Film, which is designed with a proprietary woven nylon structure that provides extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications. Such developments are anticipated to increase their adoption across the biopharmaceutical industry over the coming years, thereby contributing to market growth.

Therefore, owing to the factors above, such as the high demand for biopharmaceutical products, several advantages offered by single-use systems, and the increasing number of new product launches, the market studied is anticipated to grow over the forecast period. However, the issues related to leachable and extractable are likely to restrain the growth of the single-use bioprocessing market over the forecast period.

Single-use Bioprocessing Industry Segmentation

As per the scope of the report, single-use bioprocessing is a fast-moving technology used to develop disposable bioprocessing equipment to manufacture biopharmaceutical products. The single-use bioprocessing market is segmented by product, application, end user, and geography. By product, the segment is bifurcated into filtration assemblies, media bags and containers, disposable/single-use bioreactors, disposable mixers, and other products. The application segment is divided into filtration, cell culture, purification, and other applications. The end-user segment is segmented into biopharmaceutical manufacturers, academic and clinical research institutes, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

The report offers the value (USD) for the above segments.